Skip to content

Public FDA record

Z-0334-2016: BD CD64 APC-R700; Analyte Specific Reagent; Model 657701; Lot No. 4344945, 5037611 and 5063945. Hematolo

Recall record Z-0334-2016 for Becton, Dickinson and Company, BD Biosciences. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0334-2016
Company in FDA record
Becton, Dickinson and Company, BD Biosciences
FDA record creation date
Nov 24, 2015
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Three lots of CD64 (MD22) are contaminated with CD4 antibody.

Source facts

Action
Urgent Product Recall letters were sent out on October 30, 2015 via certified mail to notify customers of the issue.
Initiated
2015-10-30
Root cause
Process control
Terminated
2016-05-27
Distribution
Distributed in the states of FL, WA, PA, IL, GA, RI, TX, ND, and IA.
Recall number
Z-0334-2016
Recall status
Terminated
CDRH record ID
141497
FDA record created
2015-11-24
Recall event number
72548

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗